Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea

Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea

Abstract Background Hypoxia can reduce the levels of soluble receptor for advanced glycation end-products (sRAGE), a new anti-inflammatory biomarker of COPD. We assessed sRAGE in patients with hypoxia-related diseases such as COPD, OSA and OSA-COPD overlap. Methods Plasma levels of sRAGE were measur...

Full description

Bibliographic Details
Main Authors: Marta Marin-Oto, David Sanz-Rubio, Fernando Santamaría-Martos, Ivan Benitez, Ana L. Simon, Marta Forner, Pablo Cubero, Ana Gil, Manuel Sanchez-de-laTorre, Ferran Barbe, José M. Marin
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Respiratory Research
Subjects:
sRAGE
Smokers
Chronic obstructive pulmonary disease
Obstructive sleep apnoea
Online Access:https://doi.org/10.1186/s12931-022-02092-9

Internet

https://doi.org/10.1186/s12931-022-02092-9

Similar Items